Gillian M Keating

Summary

Publications

  1. doi request reprint Tbo-Filgrastim: A Review in Neutropenic Conditions
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    BioDrugs 30:153-60. 2016
  2. doi request reprint Diclofenac sodium injection (akis(®), dicloin (®)): a review of its use in the management of pain
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Clin Drug Investig 35:397-404. 2015
  3. doi request reprint Fentanyl Iontophoretic Transdermal System: A Review in Acute Postoperative Pain
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Clin Drug Investig 36:321-30. 2016
  4. doi request reprint Alirocumab: A Review in Hypercholesterolemia
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Am J Cardiovasc Drugs 16:141-52. 2016
  5. doi request reprint Afamelanotide: A Review in Erythropoietic Protoporphyria
    Esther S Kim
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Am J Clin Dermatol 17:179-85. 2016
  6. doi request reprint Cobimetinib Plus Vemurafenib: A Review in BRAF (V600) Mutation-Positive Unresectable or Metastatic Melanoma
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 76:605-15. 2016
  7. doi request reprint therascreen (®) EGFR RGQ PCR Kit: A Companion Diagnostic for Afatinib and Gefitinib in Non-Small Cell Lung Cancer
    Yahiya Y Syed
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Mol Diagn Ther 20:191-8. 2016
  8. doi request reprint Dichlorphenamide: A Review in Primary Periodic Paralyses
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Drugs 76:501-7. 2016
  9. doi request reprint Adjunctive Brexpiprazole: A Review in Major Depressive Disorder
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    CNS Drugs 30:91-9. 2016
  10. doi request reprint Lenvatinib: A Review in Refractory Thyroid Cancer
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Target Oncol 11:115-22. 2016

Collaborators

Detail Information

Publications363 found, 100 shown here

  1. doi request reprint Tbo-Filgrastim: A Review in Neutropenic Conditions
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    BioDrugs 30:153-60. 2016
    ..Current evidence indicates that tbo-filgrastim is a useful alternative to reference filgrastim in patients requiring filgrastim therapy for various neutropenic conditions. ..
  2. doi request reprint Diclofenac sodium injection (akis(®), dicloin (®)): a review of its use in the management of pain
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Clin Drug Investig 35:397-404. 2015
    ..Thus, diclofenac HPβCD 25, 50 or 75 mg/mL solution for subcutaneous or intramuscular injection extends the treatment options available for use in the management of pain in adults. ..
  3. doi request reprint Fentanyl Iontophoretic Transdermal System: A Review in Acute Postoperative Pain
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Clin Drug Investig 36:321-30. 2016
    ..Hence, fentanyl ITS is a useful option for the management of acute postoperative pain in adults requiring opioid analgesia in the hospital setting. ..
  4. doi request reprint Alirocumab: A Review in Hypercholesterolemia
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Am J Cardiovasc Drugs 16:141-52. 2016
    ....
  5. doi request reprint Afamelanotide: A Review in Erythropoietic Protoporphyria
    Esther S Kim
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Am J Clin Dermatol 17:179-85. 2016
    ..Afamelanotide, approved in the EU for the prevention of EPP phototoxicity, represents a useful addition to the management of the disorder. ..
  6. doi request reprint Cobimetinib Plus Vemurafenib: A Review in BRAF (V600) Mutation-Positive Unresectable or Metastatic Melanoma
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 76:605-15. 2016
    ..Cobimetinib plus vemurafenib had a manageable tolerability profile. In conclusion, cobimetinib plus vemurafenib is a valuable option for use in BRAF (V600) mutation-positive unresectable or metastatic melanoma. ..
  7. doi request reprint therascreen (®) EGFR RGQ PCR Kit: A Companion Diagnostic for Afatinib and Gefitinib in Non-Small Cell Lung Cancer
    Yahiya Y Syed
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Mol Diagn Ther 20:191-8. 2016
    ..The clinical utility of the kit has been validated in phase 3 or 4 trials in which NSCLC patients with EGFR mutations as detected by the kit had greater clinical benefits with afatinib or gefitinib than with standard chemotherapy. ..
  8. doi request reprint Dichlorphenamide: A Review in Primary Periodic Paralyses
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Drugs 76:501-7. 2016
    ..As the first agent to be approved in the USA for this indication, dichlorphenamide is a valuable treatment option for patients with primary hyperkalaemic or hypokalaemic periodic paralysis. ..
  9. doi request reprint Adjunctive Brexpiprazole: A Review in Major Depressive Disorder
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    CNS Drugs 30:91-9. 2016
    ..Results of ongoing trials should help position the drug in the treatment of MDD. In the meantime, brexpiprazole provides a valid option for patients with persistent symptoms despite standard antidepressant therapy. ..
  10. doi request reprint Lenvatinib: A Review in Refractory Thyroid Cancer
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Target Oncol 11:115-22. 2016
    ..Lenvatinib, therefore, offers an acceptable alternative to sorafenib - currently, the only other TKI approved for this indication. ..
  11. doi request reprint Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Target Oncol 11:107-14. 2016
    ..Thus, panobinostat, in combination with bortezomib and dexamethasone, is a useful addition to the available treatment options for patients with relapsed or refractory MM. ..
  12. doi request reprint Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Drugs 76:363-74. 2016
    ..To conclude, once-daily subcutaneous insulin glargine 300 U/mL is an effective and generally well tolerated basal insulin therapy option for patients with type 1 or type 2 diabetes. ..
  13. doi request reprint Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 76:387-96. 2016
    ..Therefore, sacubitril/valsartan is a more effective replacement for an ACE inhibitor or an ARB in the treatment of HFrEF, and is likely to influence the basic approach to treatment. ..
  14. doi request reprint Pembrolizumab: A Review in Advanced Melanoma
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Drugs 76:375-86. 2016
    ..Thus, pembrolizumab is a valuable treatment option for patients with advanced melanoma, including those who have progressed on ipilimumab and BRAF/MEK inhibitors. ..
  15. doi request reprint Oritavancin: a review in acute bacterial skin and skin structure infections
    Yahiya Y Syed
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1891-902. 2015
    ..Therefore, oritavancin is a useful treatment option for adults with ABSSSI. ..
  16. doi request reprint Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    BioDrugs 30:41-8. 2016
    ....
  17. doi request reprint Vilazodone: a review in major depressive disorder in adults
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:1915-23. 2015
    ..Vilazodone had only limited adverse effects on sexual function or bodyweight. Therefore, vilazodone is an effective agent for treating MDD in adults. ..
  18. doi request reprint Axitinib: a review in advanced renal cell carcinoma
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1903-13. 2015
    ..In conclusion, axitinib is an important option in previously-treated patients with advanced RCC. ..
  19. doi request reprint Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Drugs 75:1797-806. 2015
    ..Although the use of tolvaptan requires careful consideration and balancing of benefits and risks, current evidence suggests that tolvaptan is a promising new treatment option for patients with ADPKD. ..
  20. doi request reprint Naltrexone ER/Bupropion ER: A Review in Obesity Management
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:1269-80. 2015
    ....
  21. doi request reprint Roflumilast: A Review in COPD
    Karly P Garnock-Jones
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Drugs 75:1645-56. 2015
    ..Roflumilast is a useful addition to the treatment options for patients with COPD...
  22. doi request reprint Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:1131-40. 2015
    ..In conclusion, nintedanib is an important new option for the treatment of IPF. ..
  23. doi request reprint Memantine ER/Donepezil: A Review in Alzheimer's Disease
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    CNS Drugs 29:963-70. 2015
    ..The fixed-dose combination is potentially more convenient than coadministration of the individual agents. ..
  24. doi request reprint Dulaglutide: A Review in Type 2 Diabetes
    Celeste B Burness
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    BioDrugs 29:407-18. 2015
    ..The most frequently reported adverse events in clinical trials were gastrointestinal-related (e.g., nausea, vomiting, and diarrhea). Thus, dulaglutide is a useful option for the treatment of adult patients with T2DM. ..
  25. doi request reprint Prucalopride: A Review in Chronic Idiopathic Constipation
    Karly P Garnock-Jones
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 76:99-110. 2016
    ..No cardiovascular safety issues have arisen with prucalopride treatment. Although further long-term and comparative data would be beneficial, prucalopride provides an additional treatment option for patients with CIC. ..
  26. doi request reprint Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1807-13. 2015
    ....
  27. doi request reprint Insulin Degludec/Liraglutide: A Review in Type 2 Diabetes
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:1523-34. 2015
    ..Thus, once-daily subcutaneous insulin degludec/liraglutide is a useful add-on therapy option for adult patients with inadequately controlled type 2 diabetes...
  28. doi request reprint Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease
    Sohita Dhillon
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1405-12. 2015
    ....
  29. doi request reprint Secukinumab: a review in moderate to severe plaque psoriasis
    Karly P Garnock-Jones
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Am J Clin Dermatol 16:323-30. 2015
    ..Subcutaneous secukinumab is an effective and generally well tolerated first-line treatment for moderate to severe plaque psoriasis, and is a useful addition to the treatment options for this disease. ..
  30. doi request reprint Bortezomib: A Review in Mantle Cell Lymphoma in Previously Untreated Patients Unsuitable for Stem-Cell Transplantation
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    BioDrugs 29:207-14. 2015
    ..Overall survival data were not mature at the time of assessment. The improved efficacy with VR-CAP was accompanied by an increased incidence of grade 3 or higher adverse events, particularly haematological adverse events. ..
  31. doi request reprint Ivermectin: A Review in Rosacea
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Am J Clin Dermatol 16:447-52. 2015
    ..Thus, ivermectin 1% cream is an effective and well tolerated option for the topical treatment of inflammatory lesions of rosacea, with the convenience of once-daily application...
  32. doi request reprint Empagliflozin/Linagliptin: A Review in Type 2 Diabetes
    Esther S Kim
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:1547-57. 2015
    ..As the first SGLT2 inhibitor/DPP-4 inhibitor fixed-dose combination available, empagliflozin/linagliptin is a useful new option for patients with T2D...
  33. doi request reprint Eliglustat: A Review in Gaucher Disease Type 1
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1669-78. 2015
    ..In the meantime, with its convenient oral regimen, eliglustat is an emerging alternative therapy to ERT for the long-term treatment of adults with GD1 who are CYP2D6 EMs, IMs or PMs...
  34. doi request reprint Raplixa™: A Review in Improving Surgical Haemostasis
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Clin Drug Investig 35:519-24. 2015
    ..Thus, Raplixa provides an easy to store and use option for improving haemostasis in adults when standard surgical techniques are ineffective or impractical. ..
  35. doi request reprint Bromfenac Ophthalmic Solution 0.07%: A Review of Its Use After Cataract Surgery
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Clin Drug Investig 35:525-9. 2015
    ..07% than placebo recipients. Thus, current evidence suggests once-daily bromfenac 0.07% extends the treatment options currently available for the management of postoperative inflammation and pain following cataract surgery...
  36. doi request reprint Carbidopa/Levodopa ER Capsules (Rytary(®), Numient™): A Review in Parkinson's Disease
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    CNS Drugs 30:79-90. 2016
    ..Thus, carbidopa/levodopa ER is an effective and generally well-tolerated treatment option for the motor symptoms of PD, reducing periods of 'off-time' compared with carbidopa/levodopa IR without increasing troublesome dyskinesia. ..
  37. doi request reprint Perindopril/amlodipine (Prestalia(®)): a review in hypertension
    Matt Shirley
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Am J Cardiovasc Drugs 15:363-70. 2015
    ..Thus, perindopril/amlodipine FDC represents a useful option for the treatment of hypertension, including as initial therapy for patients likely to require multiple drugs to achieve their BP targets. ..
  38. doi request reprint Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:2017-24. 2015
    ..Given its efficacy and tolerability, intravenous nab-paclitaxel plus carboplatin is a valuable first-line treatment option for patients with advanced NSCLC...
  39. doi request reprint Darunavir: A Review in Pediatric HIV-1 Infection
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Paediatr Drugs 17:411-21. 2015
    ....
  40. doi request reprint Dimethyl Fumarate: A Review in Relapsing-Remitting MS
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 76:243-54. 2016
    ....
  41. doi request reprint Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Drugs 76:255-62. 2016
    ..Thus, subcutaneous asfotase alfa is a valuable emerging therapy for the treatment of bone manifestations in patients with paediatric-onset HPP. ..
  42. doi request reprint Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    CNS Drugs 29:425-32. 2015
    ..Thus, in the treatment of RRMS, glatiramer acetate 40 mg/mL three times weekly is effective and provides a better tolerated and possibly more convenient option than the once-daily regimen...
  43. doi request reprint Saxagliptin: A Review in Type 2 Diabetes
    Sohita Dhillon
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1783-96. 2015
    ..Although further long-term data will be beneficial, current evidence indicates that saxagliptin is a useful option for the treatment of patients with type 2 diabetes. ..
  44. doi request reprint Nivolumab: a review in advanced squamous non-small cell lung cancer
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Drugs 75:1925-34. 2015
    ..In conclusion, nivolumab represents an important advance in previously-treated, advanced, squamous NSCLC. ..
  45. doi request reprint Evolocumab: A Review in Hyperlipidemia
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Am J Cardiovasc Drugs 16:67-78. 2016
    ....
  46. doi request reprint Lenalidomide: a review of its continuous use in patients with newly diagnosed multiple myeloma not eligible for stem-cell transplantation
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs Aging 32:409-18. 2015
    ..In conclusion, continuous lenalidomide regimens provide an effective longer-term treatment option in patients with newly diagnosed multiple myeloma ineligible for stem-cell transplantation...
  47. doi request reprint Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Paediatr Drugs 18:75-81. 2016
    ....
  48. doi request reprint Nivolumab: A Review in Advanced Melanoma
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1413-24. 2015
    ....
  49. doi request reprint Ceftolozane/Tazobactam: A Review in Complicated Intra-Abdominal and Urinary Tract Infections
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 76:231-42. 2016
    ....
  50. doi request reprint Extended-Cycle Levonorgestrel/Ethinylestradiol and Low-Dose Ethinylestradiol (Seasonique(®)): A Review of Its Use as an Oral Contraceptive
    Celeste B Burness
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1019-26. 2015
    ..Seasonique(®) extends the contraceptive options currently available to women, particularly in those who desire fewer withdrawal bleeding episodes. ..
  51. doi request reprint Pasireotide in Acromegaly: A Review
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:1039-48. 2015
    ..Thus, in the treatment of acromegaly, pasireotide may be a more effective somatostatin analogue than other approved agents of the same class; however, the increased risk of hyperglycaemia needs to be considered and proactively managed. ..
  52. doi request reprint Cangrelor: A Review in Percutaneous Coronary Intervention
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1425-34. 2015
    ..In conclusion, intravenous cangrelor is an important new option for use in patients undergoing PCI who have not been treated with oral P2Y12 inhibitors...
  53. doi request reprint Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism
    Esther S Kim
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1293-303. 2015
    ....
  54. doi request reprint Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:1119-30. 2015
    ..In conclusion, dexmedetomidine is an important option for sedation in the intensive care setting. ..
  55. doi request reprint Aflibercept: A Review in Metastatic Colorectal Cancer
    Yahiya Y Syed
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:1435-45. 2015
    ..In conclusion, aflibercept plus FOLFIRI is a useful treatment option for patients with metastatic colorectal cancer previously treated with an oxaliplatin-containing regimen, with or without bevacizumab...
  56. doi request reprint Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1281-91. 2015
    ....
  57. doi request reprint Perampanel: A Review in Drug-Resistant Epilepsy
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:1657-68. 2015
    ....
  58. doi request reprint Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain
    Celeste B Burness
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 76:123-34. 2016
    ..The capsaicin 8 % patch was associated with expected, transient, capsaicin-related application-site adverse events such as erythema and pain. ..
  59. doi request reprint Bivalent rLP2086 Vaccine (Trumenba(®)): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10-25 Years
    Matt Shirley
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    BioDrugs 29:353-61. 2015
    ..Although some questions remain, including the duration of the protective response, rLP2086 vaccine has the potential to be a valuable tool for the prevention of invasive MenB disease...
  60. doi request reprint Regorafenib: A Review of Its Use in Patients with Advanced Gastrointestinal Stromal Tumours
    Matt Shirley
    Adis, Level 1, 5 The Warehouse Way, Northcote 0627, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1009-17. 2015
    ..In conclusion, regorafenib presents a valuable new tool in the treatment of patients with advanced GISTs following the failure of imatinib and sunitinib. ..
  61. doi request reprint Teneligliptin: a review in type 2 diabetes
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, Auckland 0754, New Zealand
    Clin Drug Investig 35:765-72. 2015
    ..In the meantime, teneligliptin is a useful treatment option for adults with T2DM who have not responded adequately to diet and exercise regimens, or the addition of antidiabetic drugs...
  62. doi request reprint Acamprosate: A Review of Its Use in Alcohol Dependence
    Greg L Plosker
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1255-68. 2015
    ..Thus, the use of acamprosate as an adjunct to psychosocial interventions in alcohol-dependent patients provides modest but potentially valuable improvements in alcohol-consumption outcomes and is generally well tolerated...
  63. doi request reprint Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:2131-41. 2015
    ..In conclusion, netupitant/palonosetron is an important option to consider in the prevention of acute and delayed CINV in patients receiving MEC or HEC...
  64. doi request reprint Lacosamide: A Review in Focal Seizures in Patients with Epilepsy
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:2143-54. 2015
    ....
  65. doi request reprint AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus
    Esther S Kim
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:1679-86. 2015
    ....
  66. doi request reprint Liraglutide: a review of its use in the management of obesity
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:899-910. 2015
    ....
  67. doi request reprint Diquafosol ophthalmic solution 3 %: a review of its use in dry eye
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:911-22. 2015
    ..In conclusion, diquafosol ophthalmic solution 3 % is a useful option for the treatment of dry eye...
  68. doi request reprint Edoxaban: a review in nonvalvular atrial fibrillation
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Am J Cardiovasc Drugs 15:351-61. 2015
    ..Therefore, edoxaban is an effective and well tolerated therapeutic option in patients with nonvalvular atrial fibrillation. ..
  69. doi request reprint Tiotropium/Olodaterol: A Review in COPD
    Sohita Dhillon
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 76:135-46. 2016
    ....
  70. doi request reprint Nintedanib: A Review of Its Use as Second-Line Treatment in Adults with Advanced Non-Small Cell Lung Cancer of Adenocarcinoma Histology
    Sohita Dhillon
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Target Oncol 10:303-10. 2015
    ..To conclude, nintedanib in combination with docetaxel is an effective treatment option for patients with advanced NSCLC of adenocarcinoma histology after first-line chemotherapy. ..
  71. doi request reprint Aflibercept: A Review of Its Use in Diabetic Macular Oedema
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:1153-60. 2015
    ..Intravitreal aflibercept was generally well tolerated in patients with diabetic macular oedema. In conclusion, intravitreal aflibercept is an important new treatment for diabetic macular oedema. ..
  72. doi request reprint Adalimumab: A Review in Chronic Plaque Psoriasis
    Celeste B Burness
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:2119-30. 2015
    ....
  73. doi request reprint Sumatriptan/Naproxen Sodium: A Review in Migraine
    Yahiya Y Syed
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 76:111-21. 2016
    ..Based on current data, sumatriptan/naproxen sodium is a useful option for the acute treatment of migraine in adolescents and adults. The fixed-dose combination may reduce pill burden and improve adherence in some patients. ..
  74. doi request reprint Edoxaban: A Review in Deep Vein Thrombosis and Pulmonary Embolism
    Matt Shirley
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    Drugs 75:2025-34. 2015
    ..Its recent approval expands the range of DOAC agents for recurrent VTE, further facilitating treatment individualization...
  75. doi request reprint Memantine extended release (28 mg once daily): a review of its use in Alzheimer's disease
    Greg L Plosker
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:887-97. 2015
    ..The most common adverse events were headache, diarrhoea and dizziness. ..
  76. doi request reprint Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir: A Review in Chronic HCV Genotype 1 Infection
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:1027-38. 2015
    ..Thus, ombitasvir/paritaprevir/ritonavir plus dasabuvir is an effective interferon-free, direct-acting antiviral regimen for use ± ribavirin in a broad range of adults chronically infected with HCV genotype 1. ..
  77. doi request reprint Ruxolitinib: A Review in Polycythaemia Vera
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1773-81. 2015
    ..Thus, for a subgroup of PV patients for whom few treatment options have existed previously, ruxolitinib provides a valid option. ..
  78. doi request reprint Apremilast: A Review in Psoriasis and Psoriatic Arthritis
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1393-403. 2015
    ....
  79. doi request reprint Ramucirumab: A Review in Advanced Gastric Cancer
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand
    BioDrugs 29:341-51. 2015
    ....
  80. doi request reprint [(18)F]Florbetaben: a review in β-amyloid PET imaging in cognitive impairment
    Yahiya Y Syed
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    CNS Drugs 29:605-13. 2015
    ..In summary, [(18)F]florbetaben is a highly accurate β-amyloid PET tracer that has the potential to support the clinical diagnosis of Alzheimer's disease and other causes of cognitive decline. ..
  81. doi request reprint Oxycodone/Naloxone PR: A Review in Severe Refractory Restless Legs Syndrome
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    CNS Drugs 29:511-8. 2015
    ....
  82. doi request reprint 13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults
    Greg L Plosker
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1535-46. 2015
    ....
  83. doi request reprint Siltuximab: A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease
    Katherine A Lyseng-Williamson
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    BioDrugs 29:399-406. 2015
    ..In the absence of a cure, siltuximab represents a significant achievement in the management of this difficult-to-treat orphan disease. ..
  84. doi request reprint Exenatide Extended-Release: An Updated Review of Its Use in Type 2 Diabetes Mellitus
    Yahiya Y Syed
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:1141-52. 2015
    ..Thus, exenatide ER is a useful treatment option in the management of type 2 diabetes. It offers a convenient, once-weekly regimen and can be administered by patients via a pen injection system or syringes and needles...
  85. doi request reprint Elecsys(®) AMH Assay: A Review in Anti-Müllerian Hormone Quantification and Assessment of Ovarian Reserve
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Mol Diagn Ther 19:245-9. 2015
    ....
  86. doi request reprint Budesonide MMX(®): a review of its use in patients with mild to moderate ulcerative colitis
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:879-86. 2015
    ..Although final data from the CONTRIBUTE study are awaited, current evidence suggests budesonide MMX(®) 9 mg extends the treatment options currently available for patients with active, mild to moderate ulcerative colitis...
  87. doi request reprint Ibrutinib: a review of its use in patients with mantle cell lymphoma or chronic lymphocytic leukaemia
    Esther S Kim
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:769-76. 2015
    ..Given its efficacy and tolerability, once-daily, oral ibrutinib is an emerging treatment option for patients with relapsed/refractory MCL or CLL and CLL patients with del 17p or TP53 mutation...
  88. doi request reprint Alogliptin: a review of its use in patients with type 2 diabetes mellitus
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:777-96. 2015
    ..In conclusion, alogliptin is a useful option for the treatment of patients with type 2 diabetes...
  89. doi request reprint Vorapaxar: a review of its use in the long-term secondary prevention of atherothrombotic events
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:797-808. 2015
    ..Based on these results, vorapaxar has been approved in the EU as an adjunctive treatment for the secondary prevention of atherothrombotic events in patients with prior MI who do not have a history of stroke, TIA or ICH...
  90. doi request reprint Canakinumab: a review of its use in the management of systemic juvenile idiopathic arthritis
    Sheridan M Hoy
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    BioDrugs 29:133-42. 2015
    ..Thus, current evidence suggests subcutaneous canakinumab extends the treatment options currently available for patients aged ≥2 years with SJIA...
  91. doi request reprint Tiotropium Respimat®: A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:809-16. 2015
    ..Thus, in patients with poorly controlled asthma despite receiving high-dose ICS and a LABA, tiotropium Respimat® provides a valuable treatment option...
  92. doi request reprint Olaparib: a review of its use as maintenance therapy in patients with ovarian cancer
    James E Frampton
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    BioDrugs 29:143-50. 2015
    ..An as yet unapproved tablet formulation of olaparib that has a lower pill burden than the capsule formulation is currently being investigated in phase III clinical studies. ..
  93. doi request reprint Ledipasvir/Sofosbuvir: a review of its use in chronic hepatitis C
    Gillian M Keating
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:675-85. 2015
    ..Oral ledipasvir/sofosbuvir was generally well tolerated. In conclusion, ledipasvir/sofosbuvir is an important new single-tablet regimen that represents a significant advance in the treatment of chronic hepatitis C...
  94. doi request reprint Albiglutide: a review of its use in patients with type 2 diabetes mellitus
    Hannah A Blair
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:651-63. 2015
    ..Thus, albiglutide is an effective and generally well tolerated treatment option for patients with inadequately controlled type 2 diabetes. ..
  95. doi request reprint Olodaterol: a review of its use in chronic obstructive pulmonary disease
    Emma D Deeks
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:665-73. 2015
    ..However, further longer-term and active comparator-controlled studies would be beneficial, including trials powered to assess COPD exacerbations...
  96. doi request reprint Teduglutide: a guide to its use in short bowel syndrome
    Kate McKeage
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Clin Drug Investig 35:335-40. 2015
    ..Subcutaneous teduglutide was generally well tolerated in clinical trials, including over the long term, with most adverse events that led to study discontinuation being gastrointestinal in origin...
  97. doi request reprint Eltrombopag: a review of its use in patients with severe aplastic anaemia
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:525-31. 2015
    ..Eltrombopag was generally well tolerated, with increased liver transaminases as the only dose-limiting toxicity. Clonal cytogenetic abnormalities were observed in 19 % of patients and dysplasia in 5 % of patients...
  98. doi request reprint Daclatasvir: a review of its use in adult patients with chronic hepatitis C virus infection
    Paul L McCormack
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:515-24. 2015
    ..In conclusion, daclatasvir is a highly effective and well tolerated, oral, once-daily, direct-acting antiviral for use in combination therapy in adult patients chronically infected with HCV...
  99. doi request reprint Abacavir/dolutegravir/lamivudine single-tablet regimen: a review of its use in HIV-1 infection
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Drugs 75:503-14. 2015
    ....
  100. doi request reprint Sucroferric oxyhydroxide: a review in hyperphosphataemia in chronic kidney disease patients undergoing dialysis
    Sarah L Greig
    Springer, Private Bag 65901, Mairangi Bay 0754, Auckland, New Zealand
    Drugs 75:533-42. 2015
    ....
  101. doi request reprint Measles-mumps-rubella-varicella combination vaccine (ProQuad): a guide to its use in children in the E.U
    Lesley J Scott
    Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand
    Paediatr Drugs 17:167-74. 2015
    ....